Even-Paz Z, Weinrauch L, Livshin R, El-On J, Greenblatt C L
Int J Dermatol. 1982 Mar;21(2):110-2. doi: 10.1111/j.1365-4362.1982.tb00517.x.
In a small-scale preliminary trial of oral rifampicin treatment was considered successful in six out of eight cutaneous leishmaniasis patients and probably effective in a seventh. The in vitro effect of rifampicin on leishmania organisms concerns inhibition of mitochondrial function or replication. The need for protozoological control in the assessment of treatment is stressed.
在一项小规模的初步试验中，口服利福平治疗对8名皮肤利什曼病患者中的6名被认为是成功的，对第7名患者可能有效。利福平对利什曼原虫的体外作用涉及抑制线粒体功能或复制。强调了在治疗评估中进行原虫学监测的必要性。
